WHY WE DO WHAT WE DO

This year, 17 million people worldwide will hear the words "You have cancer.”

Phase I clinical trials are an indispensable step in moving new, safer cancer treatments from the lab into everyday patient care. PHASE ONE invests in the very best ideas and innovative research at the earliest stages, in all types of cancer, including rare types that are seriously underfunded.

Founder, Alberto Valner, speaks about his personal experience with cancer.

Board Member, Mieke Neumann shares why she believes in clinical trials.

Founding member, Mark Freeman, is passionate about giving back.